Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Xyphos Biosciences
Xyphos Biosciences
Corporate and regulatory developments over the Christmas period
Corporate and regulatory developments over the Christmas period
EP Vantage
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Flag link:
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Reuters
Astellas
Xyphos Biosciences
M&A
Audentes Therapeutics
Flag link:
Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T
Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T
Endpoints
CAR-T
Xyphos Biosciences
Flag link:
